tldrdailynews.com logo
Tag

Ovarian Cancer

All articles tagged with #ovarian cancer

IVF and cancer risk: overall rates similar, but small increases for some cancers
health29 days ago

IVF and cancer risk: overall rates similar, but small increases for some cancers

A large Australian study of 417,984 women who received fertility treatments (IVF, insemination, or clomiphene citrate) found the overall cancer rate was similar to the general population. However, clomiphene citrate users had a 1.04× higher cancer rate (~8.6 extra cancers per 100,000 women per year), and rates of uterine cancer, ovarian cancer (except for clomiphene users), and melanoma were 1.07–1.83× higher. Conversely, cervical and lung cancers were 1.43–1.92× lower. The study cannot establish causation and likely reflects underlying risk factors (eg, endometriosis, ethnicity, smoking) and screening practices, with absolute cancer numbers remaining small. Routine cancer screening remains important for anyone undergoing fertility treatment.

via The Conversation|
#cancer#fertility-treatment#health
Tribute to a fitness pioneer: Stephanie Buttermore dies at 36, fiancé confirms
health1 month ago

Tribute to a fitness pioneer: Stephanie Buttermore dies at 36, fiancé confirms

Fitness influencer and doctor Stephanie Buttermore has died at 36, as fiancé Jeff Nippard announced the death was sudden. She researched ovarian cancer and championed healthy weight gain and body positivity, notably through her All In challenge, and had stepped away from social media in 2024 for mental health; details about the cause of death were not released.

via Fox News|
#all-in-challenge#body-positivity#health
Influencer Stephanie Buttermore Dies at 35; Death Cause Not Disclosed
lifestyle1 month ago

Influencer Stephanie Buttermore Dies at 35; Death Cause Not Disclosed

Fitness influencer and scientist Stephanie Buttermore, longtime partner of Jeff Nippard, died at 35. A statement from Nippard’s team said she passed away but did not disclose a cause. Fans had noted her two-year social media absence; her last post in 2024 discussed anxiety and taking a break from social media. Her PhD research was in ovarian cancer, but no official reason for her death has been released.

via BollywoodShaadis|
#anxiety#death#jeff-nippard
Ombudsman links cancer patient’s death to NHS delays; Essex trust vows reforms
health2 months ago

Ombudsman links cancer patient’s death to NHS delays; Essex trust vows reforms

The Parliamentary and Health Service Ombudsman found delays of 49 days to diagnose and 81 days to start treatment for terminal ovarian cancer at Mid and South Essex NHS Foundation Trust, far exceeding targets, contributing to the patient’s death; the trust apologized and outlined reforms to speed waiting times.

via The Independent|
#diagnostic-delays#health#mid-and-south-essex-nhs-foundation-trust
Christiane Amanpour Announces Ovarian Cancer's Return and Urges Body Awareness
health5 months ago

Christiane Amanpour Announces Ovarian Cancer's Return and Urges Body Awareness

Christiane Amanpour announced her ovarian cancer has returned for a third time, but she is managing it well and emphasizes the importance of listening to one's body and having a strong support system. She shared her journey publicly to raise awareness and highlight the significance of early diagnosis and community support in battling cancer.

via Yahoo News Singapore|
#cancer-recurrence#christiane-amanpour#health
Ovarian Cancer Patient Claims Symptoms Were Ignored by Medical Staff
health6 months ago

Ovarian Cancer Patient Claims Symptoms Were Ignored by Medical Staff

Natasha Reynolds, a 23-year-old woman from Sheffield, experienced an 18-month delay in ovarian cancer diagnosis due to her symptoms being dismissed by doctors as IBS or endometriosis, highlighting the need for better listening and investigation by medical professionals. Now cancer-free after surgery, she urges women to advocate for themselves and for doctors to take persistent symptoms seriously, as new NHS guidelines aim to improve early diagnosis.

via BBC|
#health#misdiagnosis#nhs
FDA Grants Breakthrough Status to Raludotatug Deruxtecan for CDH6-Expressing Ovarian and Gynecologic Cancers
healthcare6 months ago

FDA Grants Breakthrough Status to Raludotatug Deruxtecan for CDH6-Expressing Ovarian and Gynecologic Cancers

Raludotatug deruxtecan has received FDA Breakthrough Therapy Designation for treating CDH6-expressing platinum-resistant ovarian, peritoneal, or fallopian tube cancers, based on promising early trial data, marking a significant step in developing new treatments for these difficult-to-treat cancers.

via Merck.com|
#cancer#fda-breakthrough-therapy#healthcare